Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-1.43%
$221.34
0% positive prob.
5-Day Prediction
-3.11%
$217.57
0% positive prob.
20-Day Prediction
-1.41%
$221.36
0% positive prob.
SEC 8-K filings with transcript text
Jan 28, 2026 · 100% conf.
1D
-1.43%
$221.34
Act: -2.19%
5D
-3.11%
$217.57
Act: -2.23%
20D
-1.41%
$221.36
Act: -6.76%
dhr-20260128False000031361600003136162026-01-282026-01-280000313616us-gaap:CommonStockMember2026-01-282026-01-280000313616dhr:A0.2SeniorNotesDue2026Member2026-01-282026-01-280000313616dhr:A2.1SeniorNotesDue2026Member2026-01-282026-01-280000313616dhr:A1.2SeniorNotesDue2027Member2026-01-282026-01-280000313616dhr:A0.45SeniorNotesDue2028Member2026-01-282026-01-280000313616dhr:A2.5SeniorNotesDue2030Member2026-01-282026-01-280000313616dhr:A0.75SeniorNotesDue2031Member2026-01-282026-01-280000313616dhr:A1.35SeniorNotesDue2039Member2026-01-282026-01-280000313616dhr:A1.8SeniorNotesDue2049Member2026-01-282026-01-28
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 28, 2026
(Exact Name of Registrant as Specified in Its Charter)
Delaware001-0808959-1995548 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington,DC (Address of Principal Executive Offices) (Zip Code)
202-828-0850 (Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par valueDHRNew York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange 2.100% Senior Notes due 2026DHR 26New York Stock Exchange 1.200% Senior Notes due 2027DHR/27New York Stock Exchange 0.450% Senior Notes due 2028DHR/28New York Stock Exchange 2.500% Senior Notes due 2030DHR 30New York Stock Exchange 0.750% Senior Notes due 2031DHR/31New York Stock Exchange 1.350% Senior Notes due 2039DHR/39New York Stock Exchange 1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On January 28, 2026, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the year ended December 31, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to Item 2.02 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
(c)Exhibits:
Exhibit No. Description
99.1 Press release — “Danaher Reports Fourth Quarter and Full Year 2025 Results”
104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:January 27, 2026By:/s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer
Jan 12, 2026 · 100% conf.
1D
-1.43%
$221.34
Act: -2.19%
5D
-3.11%
$217.57
Act: -2.23%
20D
-1.41%
$221.36
Act: -6.76%
dhr-20260112False000031361600003136162026-01-122026-01-120000313616us-gaap:CommonStockMember2026-01-122026-01-120000313616dhr:A0.2SeniorNotesDue2026Member2026-01-122026-01-120000313616dhr:A2.1SeniorNotesDue2026Member2026-01-122026-01-120000313616dhr:A1.2SeniorNotesDue2027Member2026-01-122026-01-120000313616dhr:A0.45SeniorNotesDue2028Member2026-01-122026-01-120000313616dhr:A2.5SeniorNotesDue2030Member2026-01-122026-01-120000313616dhr:A0.75SeniorNotesDue2031Member2026-01-122026-01-120000313616dhr:A1.35SeniorNotesDue2039Member2026-01-122026-01-120000313616dhr:A1.8SeniorNotesDue2049Member2026-01-122026-01-12
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 12, 2026
(Exact Name of Registrant as Specified in Its Charter)
Delaware001-0808959-1995548 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington,DC (Address of Principal Executive Offices) (Zip Code)
202-828-0850 (Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par valueDHRNew York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange 2.100% Senior Notes due 2026DHR 26New York Stock Exchange 1.200% Senior Notes due 2027DHR/27New York Stock Exchange 0.450% Senior Notes due 2028DHR/28New York Stock Exchange 2.500% Senior Notes due 2030DHR 30New York Stock Exchange 0.750% Senior Notes due 2031DHR/31New York Stock Exchange 1.350% Senior Notes due 2039DHR/39New York Stock Exchange 1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On January 12, 2026, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference on January 13, 2026 Danaher Corporation issued a press release regarding the Company’s estimated financial performance for the fourth quarter of 2025 and furnished pursuant to Item 2.02 of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher’s estimated financial performance for 2025. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
(c)Exhibits:
Exhibit No. Description
99.1 Press release — “Danaher CEO to Comment on Financial Performance”
99.1PRESelected Danaher Presentation Slides for J.P. Morgan Healthcare Conference on January 13, 2026
104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:January 12, 2026By:/s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer
Oct 21, 2025
dhr-20251021false000031361600003136162025-10-212025-10-210000313616us-gaap:CommonStockMember2025-10-212025-10-210000313616dhr:A0.2SeniorNotesDue2026Member2025-10-212025-10-210000313616dhr:A2.1SeniorNotesDue2026Member2025-10-212025-10-210000313616dhr:A1.2SeniorNotesDue2027Member2025-10-212025-10-210000313616dhr:A0.45SeniorNotesDue2028Member2025-10-212025-10-210000313616dhr:A2.5SeniorNotesDue2030Member2025-10-212025-10-210000313616dhr:A0.75SeniorNotesDue2031Member2025-10-212025-10-210000313616dhr:A1.35SeniorNotesDue2039Member2025-10-212025-10-210000313616dhr:A1.8SeniorNotesDue2049Member2025-10-212025-10-21
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 21, 2025
(Exact Name of Registrant as Specified in Its Charter)
Delaware001-0808959-1995548 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington,DC (Address of Principal Executive Offices) (Zip Code)
202-828-0850 (Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par valueDHRNew York Stock Exchange 0.200% Senior Notes due 2026DHR/26New York Stock Exchange 2.100% Senior Notes due 2026DHR 26New York Stock Exchange 1.200% Senior Notes due 2027DHR/27New York Stock Exchange 0.450% Senior Notes due 2028DHR/28New York Stock Exchange 2.500% Senior Notes due 2030DHR 30New York Stock Exchange 0.750% Senior Notes due 2031DHR/31New York Stock Exchange 1.350% Senior Notes due 2039DHR/39New York Stock Exchange 1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On October 21, 2025, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended September 26, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to Item 2.02 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
(c)Exhibits:
Exhibit No. Description
99.1 Press release — “Danaher Reports Third Quarter 2025 Results”
104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:October 20, 2025By:/s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer
This page provides Danaher Corporation (DHR) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on DHR's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.